This respiratory illness season, wearing a mask is required in patient and resident areas at Sunnybrook. Read our visitor guidelines »

Cancer trials
Hospital  >  Care Programs  >  Odette Cancer Program  >  Clinical trials

Cancer trials: Search results

Results: 151 items found. Showing page 1 of 6.

Development of new primary prostate cancer cell lines

Trial short name: PCa Cell Growth

Two Stereotactic MRI-Guided Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer

Trial short name: 2SMART

5 Fractions of Pelvic SABR with Intra prostatic SABR Boost: A Phase II Study

Trial short name: 5STAR (PHART 14)

Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax

Trial short name: Abbvie LIVEN

Men With Prostate Cancer on Active Surveillance - An Update of the Odette Cancer Centre Experience

Trial short name: Active Surveillance

A Phase 3 Trial of Fianlimab (anti-LAG-3) and Cemiplimab versus Pembrolizumab in the Adjuvant Setting in Patients with Completely Resected High-risk Melanoma

Trial short name: ADJ LAG3

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

Trial short name: AGCT 1531

AGIOS A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of AG-881 in Subjects with Residual or Recurrent Grade 2 Glioma with an IDH1 or IDH2 Mutation

Trial short name: AGIOS

An Internet-delivered Intervention for Re-adjustment to Sexual Intimacy with a Permanent Ostomy after Colorectal Cancer

Trial short name: An Internet-delivered Intervention for Re-adjustment to Sexual Intimacy with a Permanent Ostomy after Colorectal Cancer

Assessment of Quality of Life and Outcomes in Patients Treated with Stereotactic Body Radiotherapy (SBRT) for Primary Renal Cell Carcinoma (RCC): AQuOS-II

Trial short name: AQUOS II

PSMA MRI Guided prOstate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER

Trial short name: ARGOS/CLIMBER

A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

Trial short name: ARRY-134

: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent

Trial short name: ARTEMIDE-Biliary01

A Phase 1b Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-110 in Combination with Abiraterone in Patients with Metastatic Prostate Cancer

Trial short name: ARVINAS

Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas

Trial short name: Astex 660

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

Trial short name: Be6A/ SGNBA-002

Men with Prostate Cancer on Active Surveillance -- An update of the Odette Cancer Centre Experience

Trial short name: Biobank

Biobanking of Prostate Cancer Patients in the Post-Therapy Setting

Trial short name: Biobank Post-Treatment

Biomarker Discovery Project in High Grade Serous Ovarian Cancer

Trial short name: BioDIVA

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions (ELEMENT-MDS)

Trial short name: BMS 025 ELEMENT

Next page >>